https://en.wikipedia.org/wiki/Building_257
http://lssf.cas.cn/en/facilities-view.jsp?id=ff8080814ff56599014ff59e677e003d
Building 257, also known as Lab 257, was a United States biological warfare research laboratory located at Fort Terry on Plum Island, New York. Originally intended for munitions storage, the facility researched anti-animal biological agents beginning in 1952 under the United States Army. Biological warfare research continued in the building under the United States Department of Agriculture (USDA) until a new laboratory was completed.
In 2004 author Michael Carroll published Lab 257: The Disturbing Story of the Government's Secret Plum Island Germ Laboratory. Many of the assertions and accusations made in the book are counter to the government's position and have been criticized and challenged. The review in Army Chemical Review concluded "Lab 257 would be cautiously valuable to someone writing a history of Plum Island, but is otherwise an example of fringe literature with a portrayal of almost every form of novelist style." The book advances the idea that Lyme disease outbreaks have originated at Plum Island and conjectures several means by which animal diseases could have left the island. Sandy Miller-Hayes, a Department of Agriculture spokesperson, told the Associated Press that Lyme disease was never studied at Plum Island.
http://lssf.cas.cn/en/facilities-view.jsp?id=ff8080814ff56599014ff59e677e003d
Wuhan National Biosafety Laboratory
The facilities to be built include test facility for fulminant disease pathogens such as Cellular Level Biosafety Level 4 Laboratory, emerging disease research facility and fulminant disease pathogen storage facility (that is, BSL-4, BSL-3 and BSL-2 , ordinary laboratory, animal feeding room and relevant supporting facilities), which will finally form a relatively complete emerging disease research unit.
After the BSL-4 laboratory is put into operation formally, it will conduct research for natural focal viruses including Ebola virus and other emerging viruses, such as researches on rapid detection system, molecular epidemiology, infectious disease etiology, therapeutic antibody, vaccine and drug evaluation, and assessment on biological risk factors, thus building a biosafety platform in China for emerging and fulminant infectious diseases in terms of isolation and identification of pathogen, building of infection models, vaccine development, biological containment and research on mechanism of interaction between pathogen and the host.